source
- FDA says it has not paused CRL releases amid transparency pushAn unnamed pharmaceutical company filed a citizen petition in April asking the FDA to change how it publicly releases Complete Response Letters, arguing the new policy conflicts with long‑standing…
- Formation Bio appoints veteran biotech leader Michael Ehlers as chief scientific officerFormation Bio, an AI-focused biotech, announced the hiring of Michael Ehlers, M.D., Ph.D., as its chief scientific officer and head of research and development. Ehlers brings a blend of academic a…